← Leaderboards
Edna B Foa
University Of Pennsylvania
$22,552,226
Attributed
$22,552,226
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.9M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,552,226 · 8
By mechanism
R01$21,878,100 · 7
R10$674,126 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Daniel Y Kimberg$4,472,714
- Jay D Amsterdam$7,349,390
- Gregory K Brown$11,203,220
- Martin E Franklin$5,257,682
- Robert J Derubeis$8,551,105
Others in their field
Top investigators on “Symptoms”
- Randall J Bateman · Washington University$155,860,406
- Judith S Hochman · New York University School Of Medicine$111,581,511
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$98,224,091
- Eric Martin McDade · Washington University$96,219,353
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
- Monica M Bertagnolli · Strang Cancer Prevention Center$85,994,687
Research focus
SymptomsAnxietyCognitive Behavior TherapyRandomizedBehavioral /Social Science Research TagAffectHuman Therapy EvaluationFollow-UpSeveritiesExposure ToPharmaceutical PreparationsProgramsHuman SubjectGuidelinesCognitive TherapyAdultDesignTreatment OutcomeLifePlacebosSiteCombination TherapyClinical ResearchBase
Grant awards (50)
2/2 Harnessing Hormonal Variation to Probe Neural Mechanisms and Optimize CBT Outcomes for OCD$685,169
R01 · FY2025 · MH · contact PI
2/2 Harnessing Hormonal Variation to Probe Neural Mechanisms and Optimize CBT Outcomes for OCD$683,481
R01 · FY2024 · MH · contact PI
2/2 Harnessing Hormonal Variation to Probe Neural Mechanisms and Optimize CBT Outcomes for OCD$681,672
R01 · FY2023 · MH · contact PI
2/2 Harnessing Hormonal Variation to Probe Neural Mechanisms and Optimize CBT Outcomes for OCD$679,864
R01 · FY2022 · MH · contact PI
2/2 Harnessing Hormonal Variation to Probe Neural Mechanisms and Optimize CBT Outcomes for OCD$700,680
R01 · FY2021 · MH · contact PI
2/2-- Attaining and Maintaining Wellness in OCD$149,984
R01 · FY2016 · MH · contact PI
2/2-Attaining and Maintaining Wellness in OCD$360,000
R01 · FY2015 · MH · contact PI
2/2-Attaining and Maintaining Wellness in OCD$360,000
R01 · FY2014 · MH · contact PI
2/2-Attaining and Maintaining Wellness in OCD$345,600
R01 · FY2013 · MH · contact PI
Treatment of Smoking Among Individuals with PTSD$458,784
R01 · FY2012 · DA · contact PI
2/2-Attaining and Maintaining Wellness in OCD$360,000
R01 · FY2012 · MH · contact PI
Treatment of Smoking Among Individuals with PTSD$633,265
R01 · FY2011 · DA · contact PI
Treatment of Smoking Among Individuals with PTSD$640,228
R01 · FY2010 · DA · contact PI
Maximizing Treatment Outcome in OCD$441,356
R01 · FY2010 · MH · contact PI
Treating Adolescents with CSA-Related PTSD$404,619
R01 · FY2010 · MH · contact PI
Treatment of Smoking Among Individuals with PTSD$634,980
R01 · FY2009 · DA · contact PI
Maximizing Treatment Outcome in OCD$437,521
R01 · FY2009 · MH · contact PI
Treating Adolescents with CSA-Related PTSD$428,602
R01 · FY2009 · MH · contact PI
Treatment of Smoking Among Individuals with PTSD$562,664
R01 · FY2008 · DA · contact PI
Naltrexone and CBT for patients with alcoholism and PTSD$543,603
R01 · FY2008 · AA · contact PI
Treating Adolescents with CSA-Related PTSD$418,648
R01 · FY2008 · MH · contact PI
Maximizing Treatment Outcome in OCD$309,689
R01 · FY2008 · MH · contact PI
Maximizing Treatment Outcome in OCD$114,945
R01 · FY2008 · MH · contact PI
Naltrexone and CBT for patients with alcoholism and PTSD$592,897
R01 · FY2007 · AA · contact PI
Treating Adolescents with CSA-Related PTSD$423,634
R01 · FY2007 · MH · contact PI
Maximizing Treatment Outcome in OCD$309,689
R01 · FY2007 · MH · contact PI
Naltrexone and CBT for patients with alcoholism and PTSD$592,323
R01 · FY2006 · AA · contact PI
Treating Adolescents with CSA-Related PTSD$433,482
R01 · FY2006 · MH · contact PI
Maximizing Treatment Outcome in OCD$317,925
R01 · FY2006 · MH · contact PI
RELATIONSHIP BETWEEN BIO. AND PSYCH. CORRELATES OF PTSD$315,272
R01 · FY2005 · MH
NALTREXONE AND CBT FOR PATIENTS WITH ALCOHOLISM AND PTSD$727,320
R01 · FY2004 · AA
RELATIONSHIP BETWEEN BIO. AND PSYCH. CORRELATES OF PTSD$366,584
R01 · FY2004 · MH
CBT AUGMENTATION OF SRI PHARMACOTHERAPY FOR OCD$356,625
R01 · FY2004 · MH
NALTREXONE AND CBT FOR PATIENTS WITH ALCOHOLISM AND PTSD$15,850
R01 · FY2004 · AA
NALTREXONE AND CBT FOR PATIENTS WITH ALCOHOLISM AND PTSD$790,325
R01 · FY2003 · AA
RELATIONSHIP BETWEEN BIO. AND PSYCH. CORRELATES OF PTSD$357,262
R01 · FY2003 · MH
CBT AUGMENTATION OF SRI PHARMACOTHERAPY FOR OCD$356,625
R01 · FY2003 · MH
NALTREXONE AND CBT FOR PATIENTS WITH ALCOHOLISM AND PTSD$783,256
R01 · FY2002 · AA
RELATIONSHIP BETWEEN BIO. AND PSYCH. CORRELATES OF PTSD$377,896
R01 · FY2002 · MH
CBT AUGMENTATION OF SRI PHARMACOTHERAPY FOR OCD$356,625
R01 · FY2002 · MH
RELATIONSHIP BETWEEN BIO. AND PSYCH. CORRELATES OF PTSD$89,156
R01 · FY2002 · MH
NALTREXONE AND CBT FOR PATIENTS WITH ALCOHOLISM AND PTSD$747,391
R01 · FY2001 · AA
FLUOXETINE &COGNITIVE BEHAVIOR THERAPY IN SOCIAL PHOBIA$395,470
R01 · FY2001 · MH
RELATIONSHIP BETWEEN BIO. AND PSYCH. CORRELATES OF PTSD$359,453
R01 · FY2001 · MH
CBT AUGMENTATION OF SRI PHARMACOTHERAPY FOR OCD$356,625
R01 · FY2001 · MH
TREATMENT OF PEDIATRIC OBSESSIVE COMPULSIVE DISORDER$342,053
R10 · FY2001 · MH
NALTREXONE AND CBT FOR PATIENTS WITH ALCOHOLISM AND PTSD$690,947
R01 · FY2000 · AA
FLUOXETINE &COGNITIVE BEHAVIOR THERAPY IN SOCIAL PHOBIA$373,489
R01 · FY2000 · MH
CBT AUGMENTATION OF SRI PHARMACOTHERAPY FOR OCD$356,625
R01 · FY2000 · MH
TREATMENT OF PEDIATRIC OBSESSIVE COMPULSIVE DISORDER$332,073
R10 · FY2000 · MH